Belluck & Fox Says New Drug Shows Promise Against Mesothelioma

New York law firm calls attention to new drug to treat pleural mesothelioma that has been cleared for additional clinical trials. New York, NY (PRWEB) May 21, 2014 Belluck & Fox, a New York law firm that represents patients with mesothelioma, has learned that a promising new drug to treat pleural mesothelioma has been approved for further clinical trials. According to a new study, the drug—currently known as VS-4718—appears to slow the growth of tumors caused by pleural mesothelioma, the most common form of the disease. Cell samples taken from patients show that VS-4718 weakens mesot

Contributor